A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Phase 2 Recruiting
24 enrolled
LASER
Phase NA Recruiting
30 enrolled
ANTARES
Phase 2 Recruiting
28 enrolled
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Phase 1 Recruiting
145 enrolled
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Phase 1/2 Recruiting
150 enrolled
Beacon-BTC
Phase 3 Recruiting
480 enrolled
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Recruiting
1,800 enrolled
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
Phase 2 Recruiting
38 enrolled
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Phase 1/2 Recruiting
31 enrolled
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/2 Recruiting
225 enrolled
RIS-TH
Phase NA Recruiting
36 enrolled
ELUCIDATE
Recruiting
400 enrolled
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Phase 2 Recruiting
164 enrolled
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 Recruiting
320 enrolled
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Phase 3 Recruiting
286 enrolled
adIVO
Phase 2 Recruiting
40 enrolled
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Recruiting
30 enrolled
FiREBOLT
Phase 1 Recruiting
241 enrolled
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Phase 4 Recruiting
16 enrolled
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Phase 1/2 Recruiting
180 enrolled
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Recruiting
100 enrolled
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Phase 1 Recruiting
12 enrolled
CHOC
Phase NA Recruiting
206 enrolled
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
Phase 1 Recruiting
110 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
HAIC-quad
Phase 2 Recruiting
25 enrolled
OLIGOMETS
Phase 2 Recruiting
54 enrolled
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Phase 1/2 Recruiting
85 enrolled
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Phase 2 Recruiting
70 enrolled
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Phase NA Recruiting
15 enrolled
ProvIDHe
Phase 3 Recruiting
220 enrolled
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Phase 1/2 Recruiting
159 enrolled
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Phase 2 Recruiting
27 enrolled
Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Phase 1 Recruiting
60 enrolled
Biobank for Cholestatic Liver Diseases.
Recruiting
9,150 enrolled
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Recruiting
300 enrolled
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Phase NA Recruiting
9 enrolled
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
Phase 2 Recruiting
62 enrolled
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Phase 2 Recruiting
80 enrolled
TOMCAT
Phase 2 Recruiting
39 enrolled
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Phase 1/2 Recruiting
796 enrolled
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Phase 1/2 Recruiting
220 enrolled
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
Phase 2 Recruiting
33 enrolled
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Phase 1/2 Recruiting
74 enrolled
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Recruiting
1,200 enrolled
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Phase 1 Recruiting
70 enrolled
BRAVE
Phase NA Recruiting
120 enrolled
FAPi-2
Recruiting
60 enrolled
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Phase 1/2 Recruiting
100 enrolled
FOENIX-CCA4
Phase 2 Recruiting
120 enrolled